| Literature DB >> 29330654 |
Erik Stenberg1,2, Yang Cao3,4, Eva Szabo5, Erik Näslund6, Ingmar Näslund5, Johan Ottosson5.
Abstract
BACKGROUND: Factors associated with risk for adverse outcome are important considerations in the preoperative assessment of patients for bariatric surgery. As yet, prediction models based on preoperative risk factors have not been able to predict adverse outcome sufficiently.Entities:
Keywords: Bariatric surgery; Morbid obesity; Postoperative complication; Prediction model; Risk factor
Mesh:
Year: 2018 PMID: 29330654 PMCID: PMC6018582 DOI: 10.1007/s11695-017-3099-2
Source DB: PubMed Journal: Obes Surg ISSN: 0960-8923 Impact factor: 4.129
Baseline characteristics
| Study group | Validation group | |||
|---|---|---|---|---|
| Operated in 2010–2014 | Missing data, | Operated in 2015 | Missing data, | |
| Individuals, | 37,811 | 6250 | ||
| Sex | 0 | 0 | ||
| Male, | 9129 (24.1%) | 1418 (22.7%) | ||
| Female, | 28,682 (75.9%) | 4832 (77.3%) | ||
| Age at operation (mean ± SD), years | 41.2 ± 11.2 | 0 | 41.2 ± 11.5 | 0 |
| Comorbidity, | 20,222 (53.5%) | 0 | 3576 (57.2%) | 0 |
| Sleep apnoea, | 3792 (10.0%) | 0 | 622 (9.9%) | 0 |
| Hypertension, | 9760 (25.8%) | 0 | 1563 (25.0%) | 0 |
| Diabetes, | 5407 (14.3%) | 0 | 761 (12.2%) | 0 |
| Dyslipidaemia, | 3802 (10.1%) | 0 | 518 (8.3%) | 0 |
| Dyspepsia/GERD, | 3970 (10.5%) | 0 | 645 (10.3%) | 0 |
| Depression, | 5609 (14.8%) | 0 | 1096 (17.5%) | 0 |
| Musculoskeletal pain, | 4905 (13.0%) | 0 | 1315 (21.0%) | 0 |
| Other condition, | 4826 (12.8%) | 248 | 465 (7.4%) | 5 |
| Previous venous thromboembolism, | 918 (2.4%) | 3645 | 182 (2.9%) | 14 |
| Smoking | 6452 | 780 | ||
| Non | 21,484 (68.5%) | 3773 (69.0%) | ||
| Active smoking | 4844 (15.4%) | 798 (12.8%) | ||
| Previous history of smoking | 5031 (13.3%) | 899 (16.4%) | ||
| BMI (mean ± SD), kg/m2 | 42.12 ± 5.66 | 0 | 41.22 ± 5.87 | 0 |
| Waist circumference (mean ± SD), cm | 126.0 ± 13.99 | 6757 | 123.3 ± 14.05 | 1080 |
| HbA1c | 41.18 ± 12.52 | 6584 | 39.48 ± 10.86 | 991 |
Risk for severe postoperative complication
| Unadjusted analyses | Adjusted analyses | ||||
|---|---|---|---|---|---|
| OR (95%CI) | OR (95%CI) | ||||
| Sex | |||||
| Men | 304 (3.4%) | Reference | Reference | Reference | Reference |
| Women | 916 (3.3%) | 0.96 (0.84–1.10) | 0.549 | 1.07 (0.88–1.30) | 0.491 |
| Age | 1.01 (1.00–1.02) | 0.009 | |||
| < 30 years | 161 (2.5%) | Reference | Reference | ||
| 30–40 years | 283 (3.0%) | 1.18 (0.97–1.44) | 0.093 | ||
| 40–50 years | 424 (3.5%) | 1.41 (1.18–1.70) | < 0.001 | ||
| 50–60 years | 289 (3.9%) | 1.58 (1.30–1.92) | < 0.001 | ||
| > 60 years | 63 (3.7%) | 1.47 (1.09–1.98) | 0.011 | ||
| Waist circumference | 1.01 (1.00–1.02) | 0.070 | |||
| < 110 cm | 92 (2.8%) | Reference | Reference | ||
| 110–125 cm | 360 (3.2%) | 1.15 (0.91–1.45) | 0.235 | ||
| 125–140 cm | 358 (3.3%) | 1.18 (0.94–1.49) | 0.158 | ||
| > 140 cm | 152 (3.1%) | 1.11 (0.86–1.45) | 0.419 | ||
| Body mass index | 0.98 (0.96–1.00) | 0.019 | |||
| < 40 kg/m2 | 496 (3.5%) | Reference | Reference | ||
| 40–50 kg/m2 | 630 (3.2%) | 0.93 (0.82–1.05) | 0.220 | ||
| 50–60 kg/m2 | 84 (2.9%) | 0.83 (0.66–1.05) | 0.116 | ||
| > 60 kg/m2 | 10 (2.9%) | 0.82 (0.43–1.54) | 0.534 | ||
| Ln HbA1c | 1.32 (1.03–1.70) | 0.031 | 1.07 (0.71–1.61) | 0.751 | |
| Comorbidity | |||||
| Sleep apnoea | 136 (3.6%) | 1.12 (0.94–1.35) | 0.208 | 0.95 (0.74–1.22) | 0.659 |
| Hypertension | 356 (3.7%) | 1.18 (1.04–1.34) | 0.010 | 0.96 (0.80–1.16) | 0.705 |
| Diabetes | 203 (3.8%) | 1.19 (1.02–1.39) | 0.026 | 1.05 (0.80–1.38) | 0.705 |
| Dyslipidaemia | 135 (3.6%) | 1.10 (0.92–1.32) | 0.298 | 0.81 (0.62–1.05) | 0.105 |
| Dyspepsia/GERD | 167 (4.3%) | 1.36 (1.15–1.60) | < 0.001 | 1.25 (1.02–1.54) | 0.034 |
| Depression | 200 (3.6%) | 1.15 (0.97–1.32) | 0.113 | 1.15 (0.95–1.39) | 0.152 |
| Musculoskeletal pain | 151 (3.1%) | 0.95 (0.80–1.13) | 0.535 | 0.90 (0.69–1.19) | 0.471 |
| Other comorbidity | 178 (3.7%) | 1.16 (0.99–1.36) | 0.075 | 1.02 (0.78–1.33) | 0.887 |
| Previous venous thromboembolism | 43 (4.8%) | 1.52 (1.11–2.07) | 0.009 | 1.29 (0.87–1.92) | 0.205 |
| History of smoking | 322 (3.3%) | 1.04 (0.91–1.19) | 0.558 | ||
| Surgical year | 0.95 (0.90–1.01) | 0.083 | |||
| 2010 | 276 (3.7%) | Reference | Reference | ||
| 2011 | 279 (3.4%) | 0.90 (0.76–1.06) | 0.215 | ||
| 2012 | 255 (3.4%) | 0.91 (0.77–1.08) | 0.293 | ||
| 2013 | 241 (3.2%) | 0.86 (0.72–1.02) | 0.091 | ||
| 2014 | 169 (2.6%) | 0.69 (0.57–0.83) | < 0.001 | ||
| Surgical access | |||||
| Laparoscopic | 1123 (3.1%) | Reference | Reference | Reference | Reference |
| Open | 68 (6.7%) | 2.21 (1.72–2.85) | < 0.001 | 1.38 (0.89–2.15) | 0.147 |
| Conversion | 29 (12.5%) | 4.42 (2.98–6.55) | < 0.001 | 3.22 (1.89–5.51) | < 0.001 |
| Operation method | |||||
| Gastric bypass | 1071 (3.2%) | Reference | Reference | Reference | reference |
| Sleeve gastrectomy | 29 (1.7%) | 0.53 (0.37–0.77) | 0.001 | 0.72 (0.48–1.06) | 0.096 |
| Duodenal switch | 8 (3.2%) | 1.00 (0.50–2.04) | 0.989 | 1.38 (0.33–5.77) | 0.658 |
| Gastric banding | 1 (0.9%) | 0.28 (0.04–2.00) | 0.204 | 0.72 (0.10–5.25) | 0.747 |
| Other | 5 (4.3%) | 1.36 (0.55–3.33) | 0.505 | 1.26 (0.46–3.45) | 0.649 |
| Revisional surgery | 106 (7.9%) | 2.68 (2.18–3.30) | < 0.001 | 2.27 (1.65–3.10) | < 0.001 |
Adjusted risk for severe postoperative complication based on standardised parameters
| Full model | Concise model | |||||
|---|---|---|---|---|---|---|
| Contribution to risk | Contribution to risk | |||||
| OR (95%CI) | % | OR (95%CI) | % | |||
| Female sex | 1.03 (0.95–1.12) | 0.520 | 2.77 | |||
| Age | 1.12 (1.03–1.22) | 0.008 | 12.24 | 1.10 (1.03–1.17) | 0.007 | 9.70 |
| Waist circumference | 1.10 (0.99–1.23) | 0.078 | 10.35 | 1.09 (1.00–1.19) | 0.059 | 8.81 |
| Body mass index | 0.99 (0.89–1.09) | 0.036 | 1.08 | 0.89 (0.82–0.98) | 0.012 | 10.76 |
| Ln HbA1c | 1.02 (0.98–1.06) | 0.700 | 1.95 | |||
| Coexisting medical condition | ||||||
| Sleep apnoea | 0.98 (0.95–1.02) | 0.661 | 1.65 | |||
| Hypertension | 1.01 (0.96–1.01) | 0.727 | 1.46 | |||
| Diabetes | 1.02 (0.98–1.07) | 0.652 | 2.36 | |||
| Dyslipidaemia | 0.94 (0.83–1.06) | 0.120 | 6.14 | |||
| Dyspepsia/GERD | 1.08 (0.93–1.06) | 0.029 | 7.65 | 1.08 (1.02–1.15) | 0.007 | 8.21 |
| Depression | 1.05 (0.98–1.12) | 0.176 | 3.30 | |||
| Musculoskeletal pain | 0.97 (0.90–1.04) | 0.381 | 3.30 | |||
| Previous venous thromboembolism | 1.04 (0.98–1.11) | 0.190 | 4.25 | |||
| Surgical year | 0.92 (0.85–0.98) | 0.016 | 8.42 | 0.91 (0.85–0.97) | 0.003 | 9.49 |
| Revisional surgery | 1.19 (1.14–1.25) | < 0.001 | 19.23 | 1.19 (1.14–1.24) | < 0.001 | 18.96 |
Fig. 1Sensitivity/specificity graph for the risk calculation model based on data from patients operated within the validation group
Fig. 2Predicted probability of severe complication per centre for patients operated in 2015